http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09504539-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 1994-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09504539-A |
| titleOfInvention | 7H-imidazo (1,2-a) pyrazin-8-one NMDA receptor antagonist |
| abstract | (57) [Summary] As an active ingredient, at least one formula (I) [in the formula, R 1 represents a hydrogen atom or an alkyl or phenyl group, and R 2 represents (a) a phenyl group, (b) a halogen atom and an alkyl group. A phenyl group substituted with one or more substituents selected from alkoxy, polyfluoroalkyl, polyfluoroalkoxy, phenyl, nitro or cyano group, (c) naphthyl group, (d) halogen atom and alkyl, A naphthyl group substituted with one or more substituents selected from alkoxy, polyfluoroalkyl, polyfluoroalkoxy, phenyl, nitro or cyano group, (e) 2-, 3- or 4-pyridyl group, ( f) halogen atom and alkyl, alkoxy, polyfluoroalkyl, polyfluoroalkoxy, fluorine 2-, 3- or 4-pyridyl group, (g) 2- or 3-furyl group substituted with one or more substituents selected from nyl, nitro or cyano group, or (h) halogen atom And a 2- or 3-furyl group substituted with one or more substituents selected from alkyl, alkoxy, polyfluoroalkyl, polyfluoroalkoxy, phenyl, nitro or cyano groups], A drug containing a salt of a compound. The present invention relates to novel compounds of formula (I) and their preparation. |
| priorityDate | 1993-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.